IL131120A0 - Quinoxalinediones - Google Patents

Quinoxalinediones

Info

Publication number
IL131120A0
IL131120A0 IL13112098A IL13112098A IL131120A0 IL 131120 A0 IL131120 A0 IL 131120A0 IL 13112098 A IL13112098 A IL 13112098A IL 13112098 A IL13112098 A IL 13112098A IL 131120 A0 IL131120 A0 IL 131120A0
Authority
IL
Israel
Prior art keywords
quinoxalinediones
Prior art date
Application number
IL13112098A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/000995 external-priority patent/WO1997032873A1/fr
Priority claimed from GBGB9715783.8A external-priority patent/GB9715783D0/en
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/EP1998/001275 external-priority patent/WO1998038186A1/fr
Publication of IL131120A0 publication Critical patent/IL131120A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13112098A 1997-02-27 1998-02-24 Quinoxalinediones IL131120A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP1997/000995 WO1997032873A1 (fr) 1996-03-09 1997-02-27 Quinoxalinediones
GBGB9715783.8A GB9715783D0 (en) 1997-02-27 1997-07-25 Quinoxalinediones
PCT/EP1998/001275 WO1998038186A1 (fr) 1997-02-27 1998-02-24 Quinoxalinediones

Publications (1)

Publication Number Publication Date
IL131120A0 true IL131120A0 (en) 2001-01-28

Family

ID=10816496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13112098A IL131120A0 (en) 1997-02-27 1998-02-24 Quinoxalinediones

Country Status (14)

Country Link
US (1) US6333326B1 (fr)
KR (1) KR100375112B1 (fr)
AP (1) AP982A (fr)
AU (1) AU723467B2 (fr)
DZ (1) DZ2437A1 (fr)
EA (1) EA001658B1 (fr)
GT (1) GT199800045A (fr)
HK (1) HK1025317A1 (fr)
IL (1) IL131120A0 (fr)
IS (1) IS5142A (fr)
MA (1) MA26474A1 (fr)
OA (1) OA11189A (fr)
PL (1) PL335501A1 (fr)
UA (1) UA58534C2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1237055C (zh) * 2000-05-19 2006-01-18 山之内制药株式会社 三唑衍生物
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
WO2008088820A2 (fr) 2007-01-16 2008-07-24 The Johns Hopkins University Antagonistes de récepteur de glutamate et procédés d'utilisation
WO2008143019A1 (fr) 2007-05-17 2008-11-27 Semiconductor Energy Laboratory Co., Ltd. Dérivé de triazole et élément émetteur de lumière, dispositif émetteur de lumière et dispositif électronique utilisant le dérivé de triazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158846A (en) 1990-10-29 1992-10-27 Olin Corporation Electrostatic color printing system utilizing an image transfer belt
IT1243990B (it) * 1990-10-30 1994-06-28 Minnesota Mining & Mfg Procedimento per preparare prodotti del bisfenolo fluorene
RU2095352C1 (ru) * 1990-11-06 1997-11-10 Яманоути Фармасьютикал Ко., Лтд. Производное сконденсированного пиразина
GB9605027D0 (en) 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones

Also Published As

Publication number Publication date
PL335501A1 (en) 2000-04-25
AU6827998A (en) 1998-09-18
OA11189A (en) 2003-05-14
IS5142A (is) 1999-07-30
AP982A (en) 2001-07-16
HK1025317A1 (en) 2000-11-10
US6333326B1 (en) 2001-12-25
DZ2437A1 (fr) 2003-01-11
MA26474A1 (fr) 2004-12-20
KR20000075717A (ko) 2000-12-26
AU723467B2 (en) 2000-08-24
GT199800045A (es) 1999-08-20
KR100375112B1 (ko) 2003-03-08
EA001658B1 (ru) 2001-06-25
EA199900688A1 (ru) 2000-04-24
UA58534C2 (uk) 2003-08-15

Similar Documents

Publication Publication Date Title
HRP970132A2 (en) Quinoxalinediones
GB9710773D0 (en) Cytofunnel arrangement
GB9705787D0 (en) Modified dendroaspins
GB9709832D0 (en) Divineh
IL131120A0 (en) Quinoxalinediones
GB9715783D0 (en) Quinoxalinediones
GB2324019B (en) Lawn-Trimmer
GB2328633B (en) Wheelbrace
GB9719645D0 (en) AppliquÚs
GB9711565D0 (en) Cafetiere
KR970056159U (ko) 광고용 형광등 소켓 구조
CA81694S (en) Tape-rule
CA80851S (en) Thermomter
CA79884S (en) Moniitor
GB9714766D0 (en) Protect-a-set
AU131610S (en) Wearstud
GB9718667D0 (en) Renovative pipeliner
AU132919S (en) Tapset
GB9715722D0 (en) C-bone
GB9707914D0 (en) Fall-safe
AU132924S (en) Tapset
GB9713141D0 (en) Seatloc
AU133533S (en) Hosereel
AU133654S (en) Mini-bed
AU133791S (en) V-nailer